Biomarkers for Risk Stratification in Lung Cancer

Abroad (travel likely)Recruiting

Conditions

Nodule Solitary Pulmonary · Non-small Cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California, United States

    Contact: Study coordinator (Mehrdad Arjomandi, MD) · cancertrials@ucsf.edu · 877-827-3222
    Contact: Principal Investigator (Mehrdad Arjomandi, M.D.)
  • San Francisco VA Medical Center, San Francisco, California, United States

    Contact: Study coordinator (Mehrdad Arjomandi, M.D.) · cancertrials@ucsf.edu · 877-827-3222
    Contact: Principal Investigator (Mehrdad Arjomandi, M.D.)
  • University of California, San Francisco, San Francisco, California, United States

    Contact: Study coordinator (Mehrdad Arjomandi, MD) · cancertrials@ucsf.edu · 877-827-3222
    Contact: Principal Investigator (Mehrdad Arjomandi, M.D.)
Study leads
  • Mehrdad Arjomandi, M.D.

    Principal Investigator

    University of California, San Francisco